CHARLEY BONNIN: Open Payments
NPI 1467007708 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 24 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $433 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $266 |
| Collegium Pharmaceutical, Inc. | 8 | $138 |
| Saluda Medical Americas, Inc. | 2 | $62 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| PFIZER INC. | 1 | $30 |
| Lundbeck LLC | 1 | $27 |
| Valinor Pharma, LLC | 1 | $20 |
Products named: PROCLAIM, Belbuca, Evoke, XTAMPZA, JOURNAVX, RELISTOR, NURTEC ODT, VYEPTI.
Industry payments across TX — which companies pay providers there.
